DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells
Tan W, Feber A, Dong L, Sarpong R, Rezaee S, Rodney S, Khetrapal P, de Winter P, Ocampo F, Jalil R, Williams N, Brew-Graves C, Kelly J. DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells. BMC Cancer 2017, 17: 767. PMID: 29141603, PMCID: PMC5688623, DOI: 10.1186/s12885-017-3758-7.Peer-Reviewed Original ResearchConceptsNon-muscle invasive bladder cancerNon-muscle invasive bladder cancer patientsBladder cancerSurveillance cystoscopyUrinary testsRisk of urinary tract infectionPresence of bladder cancerHigh grade bladder cancerDetection of bladder cancerProspective multicentre observational studyRecurrent bladder cancerUpper tract imagingInvasive bladder cancerUrinary sediment cellsUrinary tract infectionNegative predictive valueMulticentre observational studyGrade bladder cancerBladder cancer surveillanceCystoscopy findingsTract infectionsUrine sample collectionHistopathological resultsCystoscopyInvasive procedures